29 December 2025 : Clinical Research
Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy
Hui Wang ABCDEFG 1*, Chenxi Huang BDE 2DOI: 10.12659/MSM.951769
Med Sci Monit 2025; 31:e951769
Table 4 Postoperative BCR Rates in PCa patients stratified by NLR, suPAR, and their combined expression levels.
| Non-recurrence (N, %) | Recurrence (N, %) | χ2 | P | |
|---|---|---|---|---|
| Low NLR (n=129) | 123 (95.35%) | 6 (4.65%) | 61.491 | <0.001 |
| High NLR (n=116) | 60 (51.72%) | 56 (48.28%) | ||
| Low suPAR (n=157) | 147 (93.63%) | 10 (6.37%) | 82.921 | <0.001 |
| High suPAR (n=88) | 36 (40.91%) | 52 (59.09%) | ||
| Low combination (n=178) | 169 (94.94%) | 9 (5.06%) | 141.210 | <0.001 |
| High combination (n=67) | 14 (20.90%) | 53 (79.10%) | ||
| Counting data were expressed as number (percentage). The Chi-square test was used, and a P value | ||||






